CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Continuous positive airway pressure (CPAP); level changesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02983825
NCT02983825N/ACompleted
CompareCT.gov

Impact of Continuous Positive Airway Pressure Level on Ventilation/Perfusion Mismatch in Premature Infants: a Phase II Clinical Trial

Children's Hospital of Philadelphia·interventional·Posted Dec 6, 2016·Updated Mar 25, 2021

In Brief

A clinical study evaluating Continuous positive airway pressure (CPAP); level changes for Infant, Premature, Diseases and Respiratory Insufficiency Syndrome of Newborn. Completed, enrolled 21 participants across 3 sites.

Detailed Summary

Continuous positive airway pressure (CPAP) is used in premature infants to maintain lungs open and facilitate gas exchange. When ventilation/perfusion (V/Q) mismatch is present, areas of the lung that are open for gas exchange do not match up with the areas of the lung that are receiving blood for gas exchange. This study measure the responsiveness of V/Q mismatch to changes in the amount (or level) of CPAP.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfant, Premature, Diseases, Respiratory Insufficiency Syndrome of Newborn
CountriesUnited States
CollaboratorsThrasher Research Fund

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 6, 2016
Enrollment StartFeb 1, 2017
Primary CompletionJul 8, 2019
Study CompletionFeb 13, 2020
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.6 years ago

Interventions

Continuous positive airway pressure (CPAP); level changesdevice

as per arm description